Abstract:OBJECTIVE:To investigate the mechanism and inhibitory effects of overexpression of 15-lipoxygenase-1 inhibiting oxygen-induced retinal neovascularization in mice.METHODS:Experimental study. Eighty-eight 7-day-old C57BL/6J mice were randomly divided into the normal control group, induced model group, gene treated group and empty vector group with 22 mice in each group. The mice with their mothers were arisen in 75% ± 2% O₂ environment for 5 days and then returned to normoxia for 5 days to establish the oxygen-induced retinopathy (OIR) model. At postnatal day 12, the gene treated group was received an intravitreous injection of Ad-15-LOX-1-EGFP at 1.0 µl, while the empty vector group was received the same volume of Ad-EGFP. At postnatal day 17, real-time PCR and Western Blot methods were used to detect the mRNA and protein expression levels of 15-LOX-1, peroxisome proliferator-activated receptor γ (PPAR-γ) , vascular endothelial growth factor-A (VEGF-A) and vascular endothelial growth factor receptor 2 (VEGFR-2) in the retina. The relative retinal non-perfusion and neovascularization areas were evaluated by FITC-dextran fluorescein angiography on flat-mounted retina. The number of endothelial cell nuclei breaking through the inner limiting membrane (ILM) was counted on hematoxylin and eosin-stained retinal section. Rank sum test and one-way ANOVA were used to assess statistical significance within groups.RESULTS:The 15-LOX-1 and PPAR-γ mRNA and protein expression levels were higher in gene treated group (15-LOX-1: 2.17 ± 0.25, 1.45 ± 0.10;PPAR-γ:2.12 ± 0.29, 0.85 ± 0.03) than those in induced model group (15-LOX-1:0.62 ± 0.03, 0.66 ± 0.04; PPAR-γ:0.67 ± 0.18, 0.48 ± 0.03) and empty vector group (15-LOX-1:0.51 ± 0.14,0.57 ± 0.03;PPAR-γ:1.07 ± 0.09,0.52 ± 0.02) ( t15-LOX-1 = 12.511, 13.402, both P < 0.01; tPPAR-r = 9.420, 6.813, both P < 0.01). On the contrary,VEGF-A and VEGFR-2 expression levels were lower in gene treated group (VEGF-A:0.87 ± 0.07, 0.34 ± 0.01; VEGFR-2:1.02 ± 0.12, 0.45 ± 0.03) than those in induced model group (VEGF-A:3.49 ± 0.53,0.74 ± 0.04; VEGFR-2:2.28 ± 0.44, 0.82 ± 0.01) and empty vector group (VEGF-A:2.30 ± 0.25,0.69 ± 0.02; VEGFR-2:1.88 ± 0.16, 0.76 ± 0.03) (tVEGF-A = 10.662, 5.843, both P < 0.01; tVEGFR-2 = 6.731, 4.763, both P < 0.01). The relative retinal non-perfusion and neovascularization areas were significantly smaller, and the number of endothelial cell nuclei breaking through the ILM was obviously lower in gene treated group(5.88 ± 1.12; 9.37 ± 1.85; 1.25 ± 0.89) than those in induced model group (21.25 ± 2.87; 24.13 ± 4.29; 60.63 ± 10.82) and empty vector group (19.50 ± 1.78; 23.13 ± 3.52; 54.63 ± 7.63) (P < 0.01; P < 0.01).CONCLUSION:Overexpression of 15-LOX-1 inhibits ORI neovascularization in mice via up-regulation of PPAR-γ and down-regulation of VEGF-A and VEGFR-2 expression.

Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy

Ghrelin Ameliorates Diabetic Retinal Injury: Potential Therapeutic Avenues for Diabetic Retinopathy

Inhibition of Reactive Oxygen Species by Lovastatin Downregulates Vascular Endothelial Growth Factor Expression and Ameliorates Blood-Retinal Barrier Breakdown in Db/db Mice: Role of NADPH Oxidase 4.

Downregulation of LOX Overexpression Promotes Retinal Ganglion Cells Survival in an Acute Ocular Hypertension Model

Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.

Effects of vascular endothelial growth factor antisense oligonucleotide combined with angiopoietin-1 on retinal vascular leakage and neovascularization in diabetic retinopathy rats

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy

Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina

Title High fat-induced upregulation of LOX-1 expression in RF/6A cells with high glucose

Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration

Liver X Receptor Modulates Diabetic Retinopathy Outcome In A Mouse Model Of Streptozotocin-Induced Diabetes

The protective effects of lycopus lucidus turcz in diabetic retinopathy and its possible mechanisms

Silencing Nogo-B improves the integrity of blood-retinal barrier in diabetic retinopathy via regulating Src, PI3K/Akt and ERK pathways

Lycium Barbarum Polysaccharides Improve Retinopathy in Diabetic Sprague-Dawley Rats

Suppression of Diabetic Retinopathy with GLUT1 Sirna.

Inhibition of Oxygen-Induced Ischemic Retinal Neovascularization with Adenoviral 15-Lipoxygenase-1 Gene Transfer via Up-Regulation of PPAR-γ and Down-Regulation of VEGFR-2 Expression

Anti-Vegf Effects of Intravitreal Erythropoietin in Early Diabetic Retinopathy

Effects of resveratrol on the Nrf 2 and HO-1 expression in diabetic vascular endothelial cells

The Effect of Lithospermic Acid, an Antioxidant, on Development of Diabetic Retinopathy in Spontaneously Obese Diabetic Rats

Overexpression of 15-Lipoxygenase-1 Inhibits Oxygen-Induced Retinal Neovascularization in Mice

GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway